#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Tuberous sclerosis complex Fatty acid oxidation disorder Malignant glioma Osteosarcoma recurrent Solitary fibrous tumour Chorioretinitis Non-Hodgkin's lymphoma unspecified histology indolent Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Primary amyloidosis Malignant peritoneal neoplasm Immune-mediated renal disorder Hepatocellular carcinoma B-cell lymphoma Autoinflammation with infantile enterocolitis Round cell liposarcoma More trials…

    Learn about Rare Diseases

    Gaucher’s disease type I – Life with Disease Wiskott-Aldrich syndrome Lymphatic malformation – Basic Information Small intestine leiomyosarcoma Myxofibrosarcoma – Treatment Rhabdomyosarcoma recurrent – Treatment Myelodysplastic syndrome – Life with Disease Rhabdomyosarcoma recurrent – Diagnostics Gastrointestinal stromal tumour Acquired haemophilia More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Valproic Acid Amisulpride ZOREVUNERSEN SODIUM Triheptanoin CAMOSTAT MESILATE Promethazine Hydrochloride Omp12 Dorocubicel AZD3632 Nvdx3 Bt8009 Dotatate Sodium Sulfate Anhydrous Dried Ferrous Sulfate Evx-01 Nms-03305293 Cefuroxime Sodium Upacicalcet Sodium Hydrate Zipalertinib Lasmiditan More therapies…

    Learn about Your Condition

    Diabetic retinal oedema Vulvovaginal pain Procedural pain Follicular lymphoma Pancreatic failure Bone marrow disorder Drug eruption Hypotonia Lysosomal storage disorder Diabetes mellitus Pancreatitis relapsing Toxic nodular goitre Pulmonary sarcoidosis Nephrotic syndrome Inborn error of metabolism More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Migraine

  • Study on Atogepant for Treating Migraine in Patients: Evaluating Effectiveness and Safety

    Not recruiting

    3 1
    Investigated Drugs:
    • Atogepant
    Belgium Czechia Germany Hungary Italy Poland +4

  • Study on Lasmiditan for Treating Migraine in Children Aged 6 to 17

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Lasmiditan
    Belgium France Germany Italy The Netherlands Romania +1

  • Study of Eptinezumab as Add-on Treatment for Prevention of Migraine in Adults with Both Migraine and Medication Overuse Headache

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Medication overuse headache
    • Migraine
    Investigated Drugs:
    • Eptinezumab
    Denmark France Germany Italy The Netherlands Norway +2

  • Study on Eptinezumab for Preventing Chronic Migraine in Adults

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Eptinezumab
    Poland Slovakia Spain

  • Study on Botulinum Toxin Type A for Patients with Treatment-Resistant Chronic Migraine

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Botulinum Toxin Type A
    • Sodium Chloride
    Norway

  • Study Comparing Atogepant and Topiramate for Preventive Treatment in Adults with Migraine

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Migraine with aura
    • Migraine without aura
    • Migraine
    Investigated Drugs:
    • Topiramate
    • Atogepant
    Austria Belgium Czechia France Germany Hungary +3
Previous Page
1 … 5 6 7 8
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!